On the 11th, Osang Healthcare (CEO Hong Seung-eok), a company specializing in in vitro diagnostics (IVD), announced that it had signed a contract with Y's Medi, a subsidiary of Yuhan Corporation, on the 8th to acquire new shares worth approximately 11 billion won, thereby increasing its stake to 22.53%.

This investment will be made through a third-party allocation of new shares, with the payment date set for March 14. Osang Healthcare will increase its stake in Y's medi from the previous 12.69% to 22.53%, further solidifying its position as the second-largest shareholder after Yuhan Corporation. Last May, the company signed an MOU with Yuhan Corporation and invested approximately 10 billion won in WiseMed as part of the collaboration.

Full article : [Yakup] Osang Healthcare makes additional investment in Yuhan Corporation subsidiary Y's Medi